Gotham Asset Management LLC Purchases Shares of 66,152 Bausch Health Companies Inc. (NYSE:BHC)

Gotham Asset Management LLC purchased a new stake in Bausch Health Companies Inc. (NYSE:BHC) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 66,152 shares of the company’s stock, valued at approximately $533,000.

A number of other hedge funds also recently bought and sold shares of BHC. Mountain Hill Investment Partners Corp. acquired a new stake in Bausch Health Companies in the 4th quarter valued at about $56,000. Bank of Nova Scotia acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $83,000. One68 Global Capital LLC acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $90,000. Balyasny Asset Management L.P. acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $97,000. Finally, Alpine Global Management LLC acquired a new stake in shares of Bausch Health Companies during the 4th quarter worth about $114,000. Institutional investors and hedge funds own 78.65% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. StockNews.com downgraded Bausch Health Companies from a “buy” rating to a “hold” rating in a research note on Saturday, May 10th. Jefferies Financial Group restated a “hold” rating and set a $8.00 price target (down previously from $12.00) on shares of Bausch Health Companies in a research note on Thursday, February 6th. Finally, Royal Bank of Canada raised their price target on Bausch Health Companies from $8.50 to $10.00 and gave the stock a “sector perform” rating in a research note on Friday, May 2nd. One investment analyst has rated the stock with a sell rating and seven have assigned a hold rating to the company’s stock. Based on data from MarketBeat, Bausch Health Companies has a consensus rating of “Hold” and an average price target of $7.42.

Bausch Health Companies Trading Down 0.6%

NYSE:BHC opened at $4.64 on Tuesday. The firm has a market cap of $1.68 billion, a P/E ratio of -38.66, a PEG ratio of 0.37 and a beta of 0.34. The stock’s 50 day simple moving average is $5.50 and its 200-day simple moving average is $6.92. Bausch Health Companies Inc. has a 12-month low of $3.96 and a 12-month high of $9.85.

Bausch Health Companies (NYSE:BHC) last released its earnings results on Wednesday, February 19th. The company reported $1.21 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.44). The company had revenue of $2.56 billion during the quarter, compared to analyst estimates of $2.51 billion. Bausch Health Companies had a negative net margin of 0.48% and a negative return on equity of 577.82%. Research analysts forecast that Bausch Health Companies Inc. will post 4.41 EPS for the current fiscal year.

Bausch Health Companies Company Profile

Bausch Health Companies Inc operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health.